Document Detail

Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan.
MedLine Citation:
PMID:  23033944     Owner:  NLM     Status:  Publisher    
BACKGROUND: Nucleic acid amplification testing (NAT) for hepatitis B virus (HBV) during blood screening has helped to prevent transfusion-transmitted HBV infection (TT-HBV) in Japan. Nevertheless, 4 to 13 TT-HBV infections arise annually. STUDY DESIGN AND METHODS: The Japanese Red Cross (JRC) analyzed repository samples of donated blood for TT-HBV that was suspected through hemovigilance. Blood donations implicated in TT-HBV infections were categorized as either window period (WP) or occult HBV infection (OBI) related. In addition, we analyzed blood from 4742 donors with low antibody to hepatitis B core antigen (anti-HBc) and antibody to hepatitis B surface antigen (anti-HBs) titers using individual-donation NAT (ID-NAT) to investigate the relationship between anti-HBc titer and proportion of viremic donors. RESULTS: Introduction of a more sensitive NAT method for screening minipools of 20 donations increased the OBI detection rate from 3.9 to 15.2 per million, while also the confirmed OBI transmission rate increased from 0.67 to 1.49 per million. By contrast the WP transmission rate decreased from 0.92 to 0.46 per million. Testing repository samples of donations missed by minipools of 20 donations NAT showed that 75 and 85% of TT-HBV that arose from WP and OBI donations, respectively, would have been interdicted by ID-NAT. The ID-NAT trial revealed that 1.94% of donations with low anti-HBc and anti-HBs titers were viremic and that anti-HBc titers and the frequency of viremia did not correlate. CONCLUSIONS: The JRC has elected to achieve maximal safety by discarding all units with low anti-HBc and anti-HBs titers that account for 1.3% of the total donations.
Rikizo Taira; Masahiro Satake; Shun'ya Momose; Satoru Hino; Yoshiharu Suzuki; Hiroyuki Murokawa; Shigeharu Uchida; Kenji Tadokoro
Related Documents :
19476564 - Development and evaluation of a vaginal ring device for sustained delivery of hiv micro...
21592434 - Primary prevention lessons learned from those with hiv in chennai, india.
9888834 - Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (pate) as an...
9873374 - Anti-aids agents. 31. synthesis and anti-hiv activity of 4-substituted 3',4'-di-o-(-)-c...
14631594 - Lamivudine prophylaxis for chemotherapy induced reactivation hepatitis b: a case report...
14730264 - Advances in the laboratory diagnosis of viral respiratory disease.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-4
Journal Detail:
Title:  Transfusion     Volume:  -     ISSN:  1537-2995     ISO Abbreviation:  Transfusion     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0417360     Medline TA:  Transfusion     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 American Association of Blood Banks.
From the Blood Service Headquarters and Central Blood Institute, Japanese Red Cross; and the Japanese Red Cross Kanto-Koshin'etsu Block Blood Center, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Influence of tip wear of piezoelectric ultrasonic scalers on root surface roughness at different wor...
Next Document:  Internalization and Intracellular Trafficking of Poly(propylene imine) Glycodendrimers with Maltose ...